Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2005 08:27 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present Preliminary Phase I Obesity Drug Data at 2005 Annual Meeting of NAASO

NEW YORK, Oct. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will present preliminary Phase I results of its obesity drug candidate, Oleoyl-estrone (OE), an experimental, orally...
October 06, 2005 09:36 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Shares to Trade on the American Stock Exchange

NEW YORK, Oct. 6, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) common shares are expected to begin trading on the American Stock Exchange tomorrow October 7 under the symbol...
September 14, 2005 16:25 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at ValueRich Small-cap Financial Expo

NEW YORK, Sept. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc.'s (OTCBB:MHTT) president and chief executive officer, Douglas Abel, will present an overview of the company and its obesity...
September 07, 2005 12:29 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Obesity Drug Safe in Phase Ia Study

NEW YORK, Sept. 7, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) said Oleoyl-estrone, its experimental obesity drug, was shown to be safe with no serious adverse events noted in a...
September 01, 2005 10:02 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Hires Redington, Inc. to Expand Reach in U.S. Investment Community

NEW YORK, Sept. 1, 2005 (PRIMEZONE) -- In an effort to expand its reach and raise awareness in the U.S. investment community, Manhattan Pharmaceuticals, Inc (OTCBB:MHTT) said it retained Redington,...
August 31, 2005 11:27 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals to Present at Oppenheimer Diabetes Conference

NEW YORK, Aug. 31, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) announced that Douglas Abel, president and chief executive officer, will present an overview of the company and its...
August 30, 2005 09:30 ET | Source: Manhattan Pharmaceuticals, Inc.

Manhattan Pharmaceuticals Raises $11.9 Million in Private Placement

NEW YORK, Aug. 30, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) completed a private placement of common stock and warrants to institutional and accredited investors resulting in...